ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

“NitroMed is pleased that these most prestigious groups in the heart failure community -- the ACC and the AHA -- have recognized the important role that BiDil therapy can play in treating heart failure in self-identified black patients. We hope that the use of BiDil according to the new heart failure guidelines will contribute to improved outcomes for black heart failure patients, who face a disproportionate burden from this serious disease.”

“CoQ10 was acknowledged in a previous American College of Cardiology/American Heart Association HF guidelines from 2005 to have a possible effect in some studies, but supplementation was not recommended until more data were available. The positive survival data from the Q-SYMBIO study and the meta-analyses of RCTs regarding ejection fraction and/or New York Heart Association classification give us a more robust documentation for CoQ10 treatment in HF.”